NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email People are starting to develop lasting connections with artificial technology. Melissa J. Perry, the dean of the College of Public Health at George Mason University, joins CBS News with more details.Read More